UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
GDTC holding history
CytoMed Therapeutics Ltd in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GDTC overviewAll 13F holders of GDTCFull Q2 2026 holdings
- Shares (Q2 2026)
- 4,831
- Value
- $4.98K
- % of portfolio
- <0.1%
- Quarters held
- 11
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 4,831 | $4.98K | <0.1% | −1,351−21.9% | Reduced | Holders |
| Q1 2026 | 6,182 | $6.18K | <0.1% | +5,117+480.5% | Added | Holders |
| Q4 2025 | 1,065 | $1.42K | <0.1% | −12,224−92.0% | Reduced | Holders |
| Q3 2025 | 13,289 | $26.4K | <0.1% | −4,292−24.4% | Reduced | Holders |
| Q2 2025 | 17,581 | $39.6K | <0.1% | +3,134+21.7% | Added | Holders |
| Q1 2025 | 14,447 | $31.5K | <0.1% | +4,349+43.1% | Added | Holders |
| Q4 2024 | 10,098 | $34.3K | <0.1% | +10,037+16,454.1% | Added | Holders |
| Q3 2024 | 61 | $96 | <0.1% | +61 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −3,500−100.0% | Sold out | Holders |
| Q4 2023 | 3,500 | $17.1K | <0.1% | +3,023+633.8% | Added | Holders |
| Q3 2023 | 477 | $1.67K | <0.1% | +423+783.3% | Added | Holders |
| Q2 2023 | 54 | $165 | <0.1% | +54 | New | Holders |